Alex Zhavoronkov | CEO
Insilico Medicine, Inc

Alex Zhavoronkov, CEO, Insilico Medicine, Inc


BioData West: Day 1 @ 15:20

Developing new drug targets for aging through novel insilico methodologies

  • Aging has become a major risk factor for many diseases including cancer, diabetes, heart disease and dementia
  • Defining new tools for the applications of aging research and information technology 
  • Empowering new business models, regulation, comprehensive and integrated set of aging biomarkers 
  • New engagements with large pharmaceutical companies and investors to fully drive the field forwards

back to speakers